Biotechnology
100 Most Popular
Most Popular Under $25

Cara Therapeutics

$19.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Pre-Market
$0.00 (0.00%) Pre-Market

Why Robinhood?

You can buy or sell CARA and other stocks, options, ETFs, and crypto commission-free!

About

CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. Read More The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Employees
55
Headquarters
Stamford, Connecticut
Founded
2004
Market Cap
771.97M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
830.13K
High Today
$19.85
Low Today
$19.15
Open Price
$19.17
Volume
282.21K
52 Week High
$24.30
52 Week Low
$11.46

Collections

Biotechnology
100 Most Popular
Most Popular Under $25
Health
Medical
Research And Development
Pharmaceutical
Technology

News

The Motley FoolMar 13

Cara Therapeutics Inc (CARA) Q4 2018 Earnings Conference Call Transcript

Cara Therapeutics Inc (NASDAQ:CARA) Q4 2018 Earnings Conference Call March 12, 2019, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon and welcome to Cara Therapeutics fourth quarter and full year 2018 financial results conference call. All participants are now in listen-only mode. There will be a question and answer session at the end. Please be advised that this call is being recorded at Cara's request. I would now like to t...

2,297
Seeking AlphaMar 13

Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q4 2018 Results - Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2018 Earnings Conference Call March 12, 2019 4:30 PM ET Company Participants Jane Urheim - Stern Investor Relations Derek Chalmers - President and Chief Executive Officer Mani Mohindru - Chief Financial Officer and Chief Strategy Officer Conference Call Participants Christopher Howerton - Jefferies & Company, Inc. Jason Gerberry - Bank of America Merrill Lynch David Amsellem - Piper Jaffray Charles Duncan - Cantor Fitzgerald & Co. Annabel Samimy - Stifel, N...

180

Earnings

-$0.62
-$0.51
-$0.40
-$0.29
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.58 per share
Actual
-$0.52 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.